Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Single-dose Study to Evaluate the Pharmacokinetics, Biotransformation and Excretion of [¹⁴C]AMG 416 in Patients With End Stage Renal Disease Receiving Dialysis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02054572
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:09.877410+00:00
Published At
2017-04-14T00:00:00+00:00
Record Updated At
2018-08-31
Results Posted At
2017-04-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-08-31"
protocolSection.identificationModule.nctId
"NCT02054572"
protocolSection.identificationModule.officialTitle
"An Open-label, Single-dose Study to Evaluate the Pharmacokinetics, Biotransformation and Excretion of [\u00b9\u2074C]AMG 416 in Patients With End Stage Renal Disease Receiving Dialysis"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-04-14"

Study condition terms

  • Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.